Last reviewed · How we verify
Metronidazol
At a glance
| Generic name | Metronidazol |
|---|---|
| Also known as | Flagyl 400mg, Novartis |
| Sponsor | University of Oslo |
| Target | Thioredoxin reductase |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Abdominal abscess
- Abscess of brain
- Abscess of liver
- Acute amebiasis
- Amebic dysentery
- Amebic liver abscess
- B. Fragilis Infections
- Bacterial endocarditis
- Bacterial septicemia
- Bacterial vaginosis
- Bacteroides Brain Abscess
- Bacteroides Empyema
- Bacteroides Endocarditis
- Bacteroides Endometritis
- Bacteroides Endomyometritis
- Bacteroides Joint Infection
- Bacteroides Liver Abscess
- Bacteroides Osteomyelitis
- Bacteroides Peritonitis
- Bacteroides Pneumonia
Common side effects
- Nausea
- Darkened urine
- Diarrhea
- Constipation
- Vomiting
- Epigastric distress
- Abdominal cramping
- Mouth: sharp, unpleasant metallic taste
- Furry tongue
- Glossitis
- Stomatitis
- Reversible neutropenia
Key clinical trials
- AI Tool to Reduce Clinician Documentation Burden (NA)
- HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids (NA)
- SOAR: Surgery Objective Analysis and Review
- Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD (NA)
- Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis (NA)
- Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study (NA)
- The STop UNhealthy Substance Use Now Trial (NA)
- Evaluation of One-Shot Vision Differential Diagnosis (OSVDE) and Multi-Step Conversational Non-Inferiority (MSCNE) in AI Medical Interviewing
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metronidazol CI brief — competitive landscape report
- Metronidazol updates RSS · CI watch RSS
- University of Oslo portfolio CI